Furthermore, autophagy inhibition by silencing ATG5 or ATG7 is able to improve chemotherapy sensitivity in high-LC3B triple-negative breast cancer [19], and anti-CD73 mAb therapy also has a similar effect [5]. This evidence concerns the gene NT5E and triple-negative breast carcinoma.